Discover 3,043 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,043
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06054776
Phase 2, Recruiting
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
for
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study,
Location: Culver City CA
Sponsor: Imugene Limited
Sex: All
Age: 18 - 70+
Code: NCT05822427
Recruiting
Pulmonary Hypertension Association Registry
for
Pulmonary Arterial Hypertension,
Location: Santa Barbara CA, Stanford CA, San Francisco CA,
Sponsor: Pulmonary Hypertension Association, Inc.
Sex: All
Age: 0+
Code: NCT04071327
Recruiting
Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.
for
Mycosis Fungoides
Location: Duarte CA
Sponsor: Sorrento Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04118868
Phase 1, Recruiting
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
for
Solid Tumor, Adult
Location: Duarte CA, San Diego CA, San Francisco CA, Seattle WA,
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06265727
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Duarte CA, Stanford CA, San Francisco CA, Phoenix AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Duarte CA, Corona CA, Portland OR, Vancouver, Conroe TX,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase 3, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Duarte CA, Orange CA, Irvine CA, Seattle WA, Chicago IL,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Location: Duarte CA, Madera CA, Phoenix AZ, Portland OR,
Sponsor: Children's Oncology Group
Sex: All
Age: 7+
Code: NCT05705531
Recruiting
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Duarte CA, Aurora CO, Houston TX, Atlanta GA, Canton OH,
Sponsor: Nerviano Medical Sciences
Sex: All
Age: 18+
Code: NCT06549790
Phase 1, Recruiting
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
for
Intracerebral Hemorrhage, Stroke, Hypertension
Location: Lancaster CA, Irvine CA, Palo Alto CA, San Antonio TX,
Sponsor: Zeenat Qureshi Stroke Institute
Sex: All
Age: 18 - 70+
Code: NCT06402968
Recruiting
Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease
for
Pilonidal Disease
Location: Los Angeles CA
Sponsor: Yosef Nasseri, MD
Sex: All
Age: 18+
Code: NCT07321704
Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Duarte CA, Orange CA, Irvine CA, Goodyear AZ, Tucson AZ,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
LYL273 for Patients With Relapsed or Refractory mCRC
for
Colorectal Cancer
Location: Duarte CA, San Francisco CA, Aurora CO, Nashville TN,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT05319314
Phase 1, Phase 2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Duarte CA, Orange CA, Irvine CA, Encinitas CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Duarte CA, Portland OR, Austin TX, Minneapolis MN,
Sponsor: Adela, Inc
Sex: All
Age: 40+
Code: NCT05366881
Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Duarte CA, Phoenix AZ, Calgary, Omaha NE, Houston TX,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase 1, Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for
Advanced Solid Tumors, HER2 Mutation
Location: Duarte CA, Houston TX, Nashville TN, Cleveland OH,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06760819
Phase 2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Duarte CA, Salt Lake City UT, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase 2, Recruiting
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer